Renin-angiotensin system

Jump to: navigation, search

WikiDoc Resources for Renin-angiotensin system

Articles

Most recent articles on Renin-angiotensin system

Most cited articles on Renin-angiotensin system

Review articles on Renin-angiotensin system

Articles on Renin-angiotensin system in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Renin-angiotensin system

Images of Renin-angiotensin system

Photos of Renin-angiotensin system

Podcasts & MP3s on Renin-angiotensin system

Videos on Renin-angiotensin system

Evidence Based Medicine

Cochrane Collaboration on Renin-angiotensin system

Bandolier on Renin-angiotensin system

TRIP on Renin-angiotensin system

Clinical Trials

Ongoing Trials on Renin-angiotensin system at Clinical Trials.gov

Trial results on Renin-angiotensin system

Clinical Trials on Renin-angiotensin system at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Renin-angiotensin system

NICE Guidance on Renin-angiotensin system

NHS PRODIGY Guidance

FDA on Renin-angiotensin system

CDC on Renin-angiotensin system

Books

Books on Renin-angiotensin system

News

Renin-angiotensin system in the news

Be alerted to news on Renin-angiotensin system

News trends on Renin-angiotensin system

Commentary

Blogs on Renin-angiotensin system

Definitions

Definitions of Renin-angiotensin system

Patient Resources / Community

Patient resources on Renin-angiotensin system

Discussion groups on Renin-angiotensin system

Patient Handouts on Renin-angiotensin system

Directions to Hospitals Treating Renin-angiotensin system

Risk calculators and risk factors for Renin-angiotensin system

Healthcare Provider Resources

Symptoms of Renin-angiotensin system

Causes & Risk Factors for Renin-angiotensin system

Diagnostic studies for Renin-angiotensin system

Treatment of Renin-angiotensin system

Continuing Medical Education (CME)

CME Programs on Renin-angiotensin system

International

Renin-angiotensin system en Espanol

Renin-angiotensin system en Francais

Business

Renin-angiotensin system in the Marketplace

Patents on Renin-angiotensin system

Experimental / Informatics

List of terms related to Renin-angiotensin system

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: RAS, RAAS

Overview

The renin-angiotensin system (RAS) or the renin-angiotensin-aldosterone system (RAAS) is a hormone system that helps regulate long-term blood pressure and extracellular volume in the body.

Activation

The system can be activated when there is a loss of blood volume or a drop in blood pressure (such as in a hemorrhage).

  1. If the perfusion of the juxtaglomerular apparatus in the kidneys decreases, then the juxtaglomerular cells release the enzyme renin.
  2. Renin cleaves an inactive peptide called angiotensinogen, converting it into angiotensin I.
  3. Angiotensin I is then converted to angiotensin II by angiotensin-converting enzyme (ACE),[1] which is found mainly in lung capillaries.
  4. Angiotensin II is the major bioactive product of the renin-angiotensin system. Angiotensin II acts as an endocrine, autocrine/ paracrine, and intracrine hormone.


Schematic depicting how the RAAS works. Here, activation of the RAAS is initiated by a low perfusion pressure in the juxtaglomerular apparatus

Effects

Angiotensin I may have some minor activity, but angiotensin II is more potent. Angiotensin II has a variety of effects on the body:

  • Throughout the body, it is a potent vasoconstrictor.
  • In the kidneys, it constricts glomerular arterioles, having a greater effect on efferent arterioles than afferent. As with most other capillary beds in the body, the constriction of afferent arterioles increases the arterioler resistance, raising systemic arterial blood pressure and decreasing the blood flow. However, the kidneys must continue to filter enough blood despite this drop in blood flow, necessitating mechanisms to keep glomerular blood pressure up. To do this, Angiotensin II constricts efferent arterioles, which forces blood to build up in the glomerulus, increasing glomerular pressure. The glomerular filtration rate (GFR) is thus maintained, and blood filtration can continue despite lowered overall kidney blood flow.
  • In the adrenal cortex, it acts to cause the release of aldosterone. Aldosterone acts on the tubules (i.e. the distal convoluted tubules and the cortical collecting ducts) in the kidneys, causing them to reabsorb more sodium and water from the urine. Potassium is secreted into the tubule in exchange for the sodium, which is reabsorbed. Aldosterone also acts on the central nervous system to increase a person's appetite for salt, and to make them feel thirsty.
  • Release of Anti Diuretic Hormone (ADH) -- also called vasopressin -- ADH is made in the hypothalamus. ADH is stored and released from the pituitary gland.

These effects directly act to increase the amount of fluid in the blood, making up for a loss in volume, and to increase blood pressure.

Clinical significance

The renin-angiotensin system is often manipulated clinically to treat high blood pressure.

Other uses of ACE

Interestingly, ACE cleaves a number of other peptides, and in this capacity is an important regulator of the kinin-kallikrein system.

Fetal renin-angiotensin system

In the fetus, the renin-angiotensin system is predominantly a sodium-losing system, as angiotensin II has little or no effect on aldosterone levels. Renin levels are high in the fetus, while angiotensin II levels are significantly lower — this is due to the limited pulmonary blood flow, preventing ACE (found predominantly in the pulmonary circulation) from having its maximum effect.

References

External links

da:Renin-angiotensin-aldosteron-systemet de:Renin-Angiotensin-Aldosteron-System he:מערכת הרנין-אנגיוטנסין-אלדוסטרון it:Sistema renina-angiotensina nl:Bloeddrukregulatie sk:Systém renín-angiotenzín-aldosterón sv:Renin-angiotensinsystemet



Linked-in.jpg